Table 1.
LVOS (n = 75) | Fresh (n = 40) | Old (n = 35) | p value | |
---|---|---|---|---|
Age | 69±15 | 66±17 | 72±13 | 0.12 |
Female gender | 41 (55) | 22 (55) | 19 (54) | 1.00 |
Risk factors | ||||
Hypertension | 51 (68) | 26 (65) | 25 (71) | 0.62 |
Hyperlipidaemia | 22 (29) | 11 (28) | 11 (31) | 0.80 |
Current nicotine | 14 (19) | 7 (18) | 7 (20) | 1.00 |
Diabetes mellitus | 11 (15) | 8 (20) | 3 (9) | 0.20 |
Family history | 12 (16) | 6 (15) | 6 (17) | 1.00 |
Atrial fibrillation | 30 (40) | 16 (40) | 14 (40) | 1.00 |
Vascular disease | 30 (40) | 15 (38) | 15 (43) | 0.65 |
TIA or stroke in history | 14 (19) | 7 (18) | 7 (20) | 1.00 |
Medication | ||||
Aspirin | 16 (21) | 8 (20) | 8 (23) | 0.79 |
Clopidogrel | 7 (9) | 3 (8) | 4 (11) | 0.70 |
OAC/DOAC | 21 (28) | 10 (25) | 11 (31) | 0.61 |
rTPA | 35 (47) | 19 (48) | 16 (46) | 0.88 |
NIHSS pre-MT | 17 (6.3) | 17 (6.0) | 18 (6.7) | 0.55 |
Baseline criteria and clinical characteristics of the total study population, and after stratification for thrombus age. Numbers are expressed as frequency (percentage) or mean ± standard deviation.
LVOS, large vessel occlusion stroke; fresh, fresh thrombus (<1 day old); old, old thrombus (>1 day old); TIA, transient ischaemic attack; OAC, oral anticoagulants; DOAC, direct oral anticoagulants; rTPA, recombinant tissue plasminogen activator (thrombolysis); NIHSS, National Institutes of Health Stroke Scale at admission to the hospital; MT, mechanical thrombectomy.